Placenta Previa
Conditions
Brief summary
Placenta previa totalis (accreta, increta, percreta); ADAMTS and proteoglycans and the oxidant / antioxidant enzyme levels.
Detailed description
Placenta previa totalis (accreta, increta, percreta) of pregnant women in the maternal serum, fetal membranes (placenta) and hysterectomy of women with myometrial strips measured the ADAMTS and proteoglycans expression levels, and the oxidant / antioxidant enzyme levels.
Interventions
None listed
Sponsors
Zekai Tahir Burak Women's Health Research and Education Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
25 Years to 40 Years
Healthy volunteers
Yes
Inclusion criteria
* pregnant women diagnosed with placenta previa by obstetric ultrasound and doppler
Exclusion criteria
* Pregnant women with comorbid diseases other than previa totalis .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of maternal serum in patients with the diagnosis of Placenta Previa (Accreta, increta, percreta) | Up to 6 months |
Secondary
| Measure | Time frame |
|---|---|
| ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of myometrial samples in patients with the diagnosis of Placenta Previa (Accreta, increta, percreta) | Up to 6 months |
| ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Fetal Membranes in patients with the diagnosis of Placenta Previa (Accreta, increta, percreta) | Up to 6 months |
| placenta previa totalis in the development, progression and in exacerbating; ADAMTS and proteoglycans, to determine the relationship of changes in expression. | Up to 2 years |
Countries
Turkey (Türkiye)
Contacts
Primary Contactsibel özler, md
Outcome results
None listed